We confirmed the status of CRELD1 mutations as modifiers for heart defects using a mouse model, where loss-of-function for CRELD1 was shown to increase cardiac septal defects when expressed on a Down syndrome mouse model background [8]. Here, CRELD1 is linked to Down syndrome.